Posted by Michael Wonder on 22 Mar 2022
Prescription medicines: new or extended uses, or new combinations of registered medicines (February 2022)
22 March 2022 - The TGA approved a new indication for 7 medicines and one vaccine in February.
The new indications are for:
- Elasomeran (Spikevax)
- Progesterone (Utrogestan)
- House dust mite allergen extract (Actair)
- Olopatadine hydrochloride with mometasone furoate (Rylatris)
- Ranibizumab (Lucentis)
- Glecaprevir with pibrentasvir (Maviret)
- Nivolumab (Opdivo)
- Secukinumab (Cosentyx)
